This is a drug designed by Hoffmann-La Roche which acts being a powerful and selective damaging allosteric modulator for team II in the metabotropic glutamate receptors (mGluR2/3), staying equipotent at mGluR2 and mGluR3 but devoid of action at other mGluR subtypes.In the web world, a big selection of molecules/substances are referred to as CEs by